We are live on ! Find out more
VIVE

VIVEVE MED INC
VIVE

Delisted

VIVE was delisted on the 18th of January, 2023.

Back to rankings

11 hedge funds and large institutions have $205K invested in VIVEVE MED INC in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

10% more funds holding

Funds holding: 10 → 11 (+1)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

6% less capital invested

Capital invested by funds: $218K → $205K (-$13K)

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ECM
ETrade Capital Management
Virginia
+$26.7K
2
Northern Trust
Northern Trust
Illinois
+$13.3K
3
Osaic Holdings
Osaic Holdings
Arizona
+$9.76K
4
Wells Fargo
Wells Fargo
California
+$46

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$31K
2
Two Sigma Investments
Two Sigma Investments
New York
-$15K
3
UBS Group
UBS Group
Switzerland
-$202

VIVE Hedge Fund Activity: Q3 2020 in Review

11 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q3 2020, worth a combined $205K — down 6% from $218K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new VIVE positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was ETrade Capital Management, opening a new position worth an estimated $26.7K. The largest seller was Jane Street, exiting entirely with an estimated $31K sold.

  • 11 institutional investors held VIVEVE MED INC (VIVE) as of Q3 2020, up from 10 in Q2 2020.
  • Funds reported $205K of VIVEVE MED INC stock for Q3 2020, down 6% quarter-over-quarter.
  • 3 funds opened new VIVEVE MED INC positions in Q3 2020 and 2 closed out, a net change of +1 holder.
  • The largest VIVEVE MED INC buyer in Q3 2020 was ETrade Capital Management, an estimated $26.7K added.
  • The largest VIVEVE MED INC seller in Q3 2020 was Jane Street, an estimated $31K sold.

Based on aggregated 13F filings for Q3 2020.